Samip Patel

Dr. Samip Patel

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 April 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
EDEugenie Du
Eugenie Du
SPSagar Patel
Sagar Patel
BHBenjamin Huang
Benjamin Huang
SPSamip Patel
Samip Patel

1 July 2016 in Oral Oncology
Verified
Journal Article
Closed access
KWKyle Wang
Kyle Wang
RARobert J. Amdur
Robert J. Amdur
WMWilliam M. Mendenhall
William M. Mendenhall
RGRebecca Green
Rebecca Green
SAShannon Aumer
Shannon Aumer
BCBhishamjit S. Chera
Bhishamjit S. Chera

1 September 2014
Verified
Journal Article
Closed access
Adam KimpleAdam Kimple
Adam Kimple
CWChris M Welch
Chris M Welch
JZJose P Zevallos
Jose P Zevallos
SPSamip Patel
Samip Patel

8 July 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
BBBlair M. Barton
Blair M. Barton
APAndrew K. Pappa
Andrew K. Pappa
JBJeffrey Blumberg
Jeffrey Blumberg
SPSamip Patel
Samip Patel
Background: Oral cavity reconstruction is very challenging anatomical subsite to reconstruct. Large defects often require free tissue reconstruction to provide the best chance of form and function. Additionally, free tissue reconstruction aids to prevent fistula formation. We aimed to determine outcomes of oral cavity defect reconstruction using scapular tip free flaps with a myogenous intraoral component.Methods: All patients with a mandibular or maxillary bony defect that included a disruption of the intraoral mucosa component between 07/1/14 and 07/31/17. Patients were reconstructed with a scapular tip free flap, which included a muscular component that was used to recreate the oral mucosa. The primary study outcomes were flap success rates, development of orocutaneous or oronasal fistula, rate of resuming oral diet as well as the occurrence of medical and surgical complications in the first month following surgery. The tested hypothesis was formulated before data collection began.Results: Twenty‐five patients were identified by the study criteria. There was one (4%) flap that failed, while orocutaneous fistula occurred in two patients (8%). Prior history of osteoradionecrosis was a statistically significant predictor of overall complication (p < .05).Conclusions: Intraoral myogenous reconstruction allows for re‐mucosalization of the oral cavity defect and is associated with high viability and low‐complication rates. In patients with amenable oral mucosal defects, a myogenous scapular tip free flap is a suitable reconstructive option.

11 March 2021 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
JWJessica Wilson
Jessica Wilson
CLCatherine Lumley
Catherine Lumley
Xianming TanXianming Tan
Xianming Tan
CSColette J Shen
Colette J Shen
ACAndrew Coniglio
Andrew Coniglio
BCBhishamjit S. Chera
Bhishamjit S. Chera
Objective: The objective of this study was to evaluate the clinical outcomes in a cohort of patients with early-stage oral tongue squamous cell carcinoma (OTSCC). Materials and Methods: We conducted a retrospective analysis of patients with pT1-T2N0 (American Joint Committee on Cancer [AJCC] seventh edition) OTSCC treated from 2000 to 2018. Two-year actuarial rates of local regional control, cancer-specific survival, and overall survival were calculated for the entire cohort and patients with/without adjuvant radiation. Results: Ninety-six patients met the criteria with a median follow-up of 4 years; 14 had adjuvant radiation, while 82 had surgery alone. Two-year local regional control was 82.7% (75.4% to 90.8%) for the entire cohort, 84.9% (77.8% to 93.2%) for surgery only, and 70.7% (50.2% to 99.6%) for patients with adjuvant radiation. Two-year progression-free survival was 82.7% (75.3% to 90.8%). Of the 20 patients with recurrence, 11 (55%) were successfully salvaged. Conclusion: Local regional recurrence remains modest in early-stage OTSCC, but salvage is possible with high survival rates. Level of Evidence: Level III—retrospective cohort study.